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Abstract
Introduction: The importance of mechanical signals in normal and inflamed cartilage is well established. 
Chondrocytes respond to changes in the levels of proinflammatory cytokines and mechanical signals during 
inflammation. Cytokines like interleukin (IL)-1β suppress homeostatic mechanisms and inhibit cartilage repair and cell 
proliferation. However, matrix synthesis and chondrocyte (AC) proliferation are upregulated by the physiological levels 
of mechanical forces. In this study, we investigated intracellular mechanisms underlying reparative actions of 
mechanical signals during inflammation.
Methods: ACs isolated from articular cartilage were exposed to low/physiologic levels of dynamic strain in the 
presence of IL-1β. The cell extracts were probed for differential activation/inhibition of the extracellular signal-
regulated kinase 1/2 (ERK1/2) signaling cascade. The regulation of gene transcription was examined by real-time 
polymerase chain reaction.
Results: Mechanoactivation, but not IL-1β treatment, of ACs initiated integrin-linked kinase activation. Mechanical 
signals induced activation and subsequent C-Raf-mediated activation of MAP kinases (MEK1/2). However, IL-1β 
activated B-Raf kinase activity. Dynamic strain did not induce B-Raf activation but instead inhibited IL-1β-induced B-Raf 
activation. Both mechanical signals and IL-1β induced ERK1/2 phosphorylation but discrete gene expression. ERK1/2 
activation by mechanical forces induced SRY-related protein-9 (SOX-9), vascular endothelial cell growth factor (VEGF), 
and c-Myc mRNA expression and AC proliferation. However, IL-1β did not induce SOX-9, VEGF, and c-Myc gene 
expression and inhibited AC cell proliferation. More importantly, SOX-9, VEGF, and Myc gene transcription and AC 
proliferation induced by mechanical signals were sustained in the presence of IL-1β.
Conclusions: The findings suggest that mechanical signals may sustain their effects in proinflammatory environments 
by regulating key molecules in the MAP kinase signaling cascade. Furthermore, the findings point to the potential of 
mechanosignaling in cartilage repair during inflammation.
Introduction
Mechanical loading during joint movement is critical for
cartilage function and survival. Chondrocytes located
within the cartilage recurrently experience mechanical
forces during joint movements. These cells sense, inter-
pret, and respond to mechanical signals to maintain tis-
sue integrity and homeostasis [1-5]. Activation of cells by
mechanical signals is a rapid process and leads to activa-
tion of several intracellular signaling cascades, flow chan-
nels, and genes [6-8]. Accumulating evidence suggests
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Page 2 of 9that chondrocytic mechanosensing is discriminatory and
capable of recognizing and responding to signals of vari-
ous magnitudes to differentially regulate cartilage repair
and pathologies [4,9].
Similarly to soluble ligands, mechanotransduction is
initiated at the matrix-membrane interface [10,11].
Chondrocytes located in the extracellular matrix are
believed to relay mechanical signals through the plasma
membrane via integrins [12,13]. Integrin-linked kinase
(ILK), located in the cytoplasmic domain of integrins,
plays a key role in transmitting mechanical signals to the
intracellular compartment [13-15]. Within the cells, Ras
(p21), Rho, and Rac belonging to the GTPase family of
proteins are stimulated following activation of ILK and
certain growth factor receptors [16,17]. Ras activation via
exchange of guanosine diphosphate (GDP) to guanosine
triphosphate (GTP) allows Ras to bind proto-oncogene c-
RAF kinases (Rafs) via Ser/Thr/Tyr phosphorylation of
A-Raf, B-Raf, and c-Raf at multiple sites [18]. Phosphory-
lated Rafs activate mitogen-activated protein kinase
(MAPK) kinase (MEK1/2) by phosphorylation of Ser217/
Ser221 [19]. Subsequently, MEK1/2 activates extracellular
receptor kinase 1/2 (ERK1/2) by phosphorylating
Thr202/Tyr204. ERK1/2 activation is associated with
growth signals. However, cytokines like interleukin-1 (IL-
1) and tumor necrosis factor-alpha (TNF-α) also phos-
phorylate ERK1/2 to regulate certain proinflammatory
genes [20,21]. Following activation, ERK1/2 translocates
to the nucleus and activates transcription factors that are
specific to the signals perceived by cells [22].
During inflammation, chondrocytes are exposed to
proinflammatory cytokines such as IL-1β and TNF-α.
These cytokines alter their chondrogenic potential, pre-
vent cell proliferation, and induce dedifferentiation and
apoptosis. Specifically, cells exposed to IL-1β lose their
ability to express SRY-related protein-9 (SOX-9) and vas-
cular endothelial cell growth factor (VEGF) [23]. How-
ever, mechanical signals are shown to be reparative and
upregulate proliferation and expression of collagen type
II and proteoglycans in articular chondrocytes (ACs).
These signals activate ERK1/2, suggesting a role for this
signaling cascade in cartilage repair [12,24]. In this study,
we investigated the intracellular signaling events respon-
sible for beneficial/reparative effects of mechanical sig-
nals during inflammation. We demonstrate that
mechanical signals and IL-1β both regulate the ERK1/2
signaling cascade but lead to activation of disparate tran-
scription factors and gene expression. Strikingly, the
actions of mechanical signals are sustained in the inflam-
matory environment and upregulate SOX-9, VEGF, and
c-Myc gene transcription as well as chondrocyte prolifer-
ation.
Materials and methods
Cell isolation, culture, and exposure to dynamic tensile or 
compressive forces
ACs were isolated from knee joints of 12- to 14-week-old,
female, Sprague Dawley rats (Charles River Laboratories,
Inc., Wilmington, MA, USA) as described earlier. Briefly,
cartilage from the condyles of femurs and tibia were asep-
tically removed, chipped, and digested in 1,400 U/mL col-
lagenase type I (Worthington Biochemical Corporation,
Lakewood, NJ, USA) for 3 hours at 37°C. The cells were
washed and grown in medium (tissue culture medium, or
TCM) containing Ham's F12, 10% fetal bovine serum
(FBS), 10 U penicillin, 10 μg/mL streptomycin, and 2 mM
glutamine (Invitrogen Corporation, Carlsbad, CA, USA).
Cells were used in the first three passages.
ACs were subjected to dynamic tensile forces (dynamic
strain, or DS) as described previously [3,25]. Briefly, ACs
(6 × 104/3 mL TCM per well) were plated in Bioflex plates
(Flexcell International Corporation, Hillsborough, NC,
USA) and cultured for 5 days to attain 70% to 80% conflu-
ence. Subsequently, 18 hours prior to exposing cells to DS
or IL-1β, the medium was replaced with TCM containing
1% FBS. Cells were exposed to DS at a magnitude of 6%
and 0.25 Hz for the required time interval and the mRNA
or proteins were extracted as described below.
Western blot analysis
Western blot assays were performed as described previ-
ously. Briefly, AC cells were lysed in Ripa buffer (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA, USA) contain-
ing protease and phosphatase inhibitor cocktail-2
(Sigma-Aldrich, St. Louis, MO, USA). The cell lysates
were subjected to SDS-10%-PAGE, electrotransferred to
a nitrocellulose membrane (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA), and reacted with antibodies to
phospho-Thr202/Tyr204 ERK1/2 and total ERK1/2,
phospho-Ser 217/221 MEK1/2 and total MEK1/2, phos-
pho-Ser338 cRaf, phospho-Ser445 B-Raf, phospho-
Thr423-PAK1, phospho-Thr58/Ser62 Myc, and total c-
Myc proteins (Cell Signaling Technology, Inc., Danvers,
MA, USA). Protein loading was normalized with total β-
actin or antibodies to total signaling molecule in each
sample. The primary antibodies were probed with horse-
radish peroxidase (HRP)- or IR-Dye 680- or IR-Dye-880-
conjugated secondary antibodies and scanned using a
Kodak 1000 Image Documentation System (Eastman
Kodak Company, Rochester, NY, USA) for HRP or an
Odyssey infrared imaging system (LI-COR Biosciences,
Lincoln, NE, USA) for IR-Dye-labeled antibodies. In
some experiments, cells were pretreated with various
inhibitors such as ERK inhibitor PD98059 (SABiosciences
Corporation, Frederick, MD, USA) or Ras inhibitor
GGT12133 (Pierce, Rockford, IL, USA) at the specified
Perera et al. Arthritis Research & Therapy 2010, 12:R106
http://arthritis-research.com/content/12/3/R106
Page 3 of 9concentrations 30 minutes prior to mechanoactivation or
IL-1 treatment or both.
RAS activation
The activated RAS in cells was estimated with an Active
Ras Pull-Down and Detection Kit (Pierce) in accordance
with the manufacturer's recommended protocol. Briefly,
glutathione-S-transferase (GST) fusion protein contain-
ing the Ras-binding domain (RBD) of Raf1 (GST-Raf1-
RBD; approximately 42 kDa) was incubated with cell
lysate and glutathione agarose beads. The active Ras
bound to the GST-Raf1-RBD was pulled down by centrif-
ugation, and active RAS was detected by Western blot
analysis using anti-Ras antibody. Control reactions using
GTPγ and GDP were performed to ensure that only
active RAS was bound to GTP.
Real-time polymerase chain reaction
Total RNA was extracted with an RNeasy Micro Kit (Qia-
gen Inc., Valencia, CA, USA), and real-time polymerase
chain reaction (RT-PCR) was conducted as described
earlier [3]. Gene-specific primers used to amplify the
cDNA (SYBR Green Master Mix; Bio-Rad Laboratories,
Inc.) were rat VEGF (sense) GCCTTGTTCAGAGCG-
GAGAAA and (anti-sense) CGCGAGTCTGTGTTTTT-
GCA, rat MYC (sense)
GGAAAACAACGAAAAGGCCC and (antisense)
TGCTCATCTGCTTGAACGGAC, and rat SOX-9
(sense) ATCTGAAGAAGGAGAGCGAG and (antisense)
CAAGCTCTGGAGACTGCTGA. Collected data were
analyzed by the comparative threshold cycle method [26].
Cell proliferation assay
The cell proliferation was examined over a 3-day period
by the MTT (3-(4,5 dimethylthiazolyl-2)-2,5-diphenyltet-
razolium bromide) cell proliferation assay (American
Type Culture Collection, Manassas, VA, USA) in accor-
dance with the manufacturer's recommended protocol.
The cells following treatment were incubated for 3 hours
with 100 μL/mL MTT (5 mg/mL Hanks' balanced salt
solution), and the formazan formation was assessed by
absorbance at 450 nm (Victor Plate Reader; PerkinElmer
Inc., Waltham, MA, USA). The cell proliferation was cal-
culated as mean absorbance of cells exposed to DS
divided by mean absorbance of controls.
Transfection of ACs with wild-type and mutant forms of 
FLAG-tagged ILK
To examine the role of ILK in ERK1/2 activation, ACs
were transfected with FLAG (polypeptide protein
sequence DYKDDDDK)-ILK expression vectors, which
were kindly provided by Chuanyue Wu, of the University
of Pittsburgh (Pittsburgh, PA, USA). ACs grown to 70%
confluence were transfected with various expression plas-
mids containing wild-type (WT) ILK cDNA (residues 1
to 145; pFLAG-WT-ILK), the kinase-deficient (KD) ILK
mutant containing a single mutation at Glu359 for Lys
(pFLAG-KD-ILK), the N-terminal deletion (residues 1 to
230; pFLAG-N-ILK), or the mock transfectants
pFLAGCMV-2 [15], using Lipofectamine 2000 (Invitro-
gen Corporation) as specified by the manufacturer.
Expression of FLAG-ILK proteins was confirmed by
immunofluorescence staining with a mouse monoclonal
anti-FLAG antibody (Sigma-Aldrich). After transfection
for 24 hours, the cells were fed with fresh selective
medium containing G418 geneticin (800 μg/mL; Invitro-
gen Corporation). Neomycin-resistant clones were cul-
tured in selective medium for another passage and then
transferred into Bioflex II six-well plates for experimenta-
tion.
Immunofluorescence staining of ACs
Immunofluorescence staining was performed as
described earlier [27]. Briefly, cells were fixed with 2%
paraformaldehyde, permeabilized with 0.2% Triton × 100
in phosphate-buffered saline, and washed and stained
with primary antibodies followed by CY3-labeled sec-
ondary antibodies. Beta-actin was stained with fluores-
cein isothiocyanate-labeled phalloidin (Sigma-Aldrich).
Results
Mechanical signals induce AC proliferation in the absence 
or presence of IL-1β
To gain insight into the actions of mechanical signals dur-
ing inflammation, we first determined AC proliferation in
the presence of IL-1β. ACs grown on Bioflex plates were
mechanoactivated for 90 minutes per day for 2 days with
medium alone or medium containing IL-1β. On day 3,
spectrophotometric determination of cells by MTT assay
revealed that exposure of ACs to mechanical signals sig-
nificantly upregulated cell proliferation. However, IL-1β
significantly suppressed AC proliferation (Figure 1a).
Mechanoactivation of ACs leads to c-Myc, VEGF, and SOX-9 
mRNA expression
VEGF, c-Myc, and SOX-9 are all involved in AC prolifera-
tion and differentiation. Therefore, we next determined
whether mRNA expression for c-Myc, VEGF, and SOX-9
is upregulated in mechanoactivated ACs in the absence
or presence of IL-1β. RT-PCR analysis showed that mech-
anoactivation of ACs significantly upregulated c-Myc,
SOX-9, and VEGF mRNA expression involved in AC pro-
liferation and differentiation (Figure 1b-d). We next
examined whether ERK1/2 activation was required for
the upregulation of mRNA expression for these genes.
ACs pretreated for 30 minutes with PD98059 (a MEK1/2-
and ERK1/2-specific inhibitor) and then exposed to DS
showed a significant suppression of DS-induced mRNA
expression for c-Myc, SOX-9, and VEGF (Figure 1b-d).
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VEGF significantly. However, PD98059 significantly abol-
ished DS-dependent c-Myc, SOX-9, and VEGF mRNA
induction in the presence of IL-1β. These findings sug-
gested that DS induces VEGF and SOX-9 mRNA expres-
sion via the ERK1/2 signaling cascade.
Mechanical signals activate ERK1/2 in the absence or 
presence of IL-1β
Since DS-induced VEGF and SOX-9 were inhibited by
PD98059, we next confirmed whether mechanical signals
induced ERK1/2 activation. DS significantly upregulated
Thr202/Tyr204-ERK1/2 phosphorylation within 10 min-
utes and was dephosphorylated in the ensuing 20 minutes
(Figure 1e). Thereafter, ERK1/2 reactivation was
observed at 60 and 120 minutes. In cells treated with IL-
1β, phosphorylation of ERK1/2 was delayed but sustained
between 30 and 60 minutes. More importantly, in cells
simultaneously exposed to IL-1β and DS, ERK1/2 was
activated within 10 minutes and was subsequently
dephosphorylated by 30 minutes. Immunofluorescence
staining of ACs revealed that the phosphorylation of
ERK1/2 was paralleled by its nuclear translocation and
cytoplasmic redistribution in cells treated with DS or
with DS and IL-1β (Figure 1f). In cells treated with IL-1β,
the majority of phospho-ERK1/2 was located in the
nuclei at 30 minutes (Figure 1f).
Mechanical signals suppress IL-1β-induced B-Raf activation
To understand how mechanical signals sustain their
effects in the presence of IL-1β, we examined the events
upstream of ERK1/2. Western blot analysis using anti-
phospho-Ser 217/221 MEK1/2 and total MEK1/2 showed
that DS induced a rapid and transient phosphorylation of
MEK1/2 within 10 minutes. IL-1-induced MEK1/2 acti-
vation was observed after 30 minutes of cell activation.
Similarly to DS alone, mechanoactivation of cells in the
presence of IL-1β showed a rapid and transient phospho-
rylation of MEK1/2 within 10 minutes (Figure 2a).
Since phosphorylation of Raf kinases is necessary for
MEK1/2 activation, we next determined whether A-Raf,
B-Raf, or c-Raf is activated by DS. DS or IL-1β did not
activate A-Raf (data not shown). DS alone or in the pres-
ence of IL-1β induced a rapid phosphorylation of Ser338
on c-Raf (Figure 2b). B-Raf was constitutively phosphory-
lated in ACs. Western blot analysis demonstrated that IL-
Figure 1 Mechanical signals upregulate articular chondrocyte (AC) proliferation via SOX-9, VEGF, and c-Myc mRNA expression and ERK1/
2 activation. ACs were exposed to no treatment or to treatment with interleukin-1-beta (IL-1β), dynamic strain (DS) alone, or DS and IL-1β. Subse-
quently, ACs were subjected to DS for 90 minutes per day for 3 days. (a) On day 4, the rate of cell proliferation was assessed by MTT assay. ACs were 
treated either with medium alone or with PD98059 (2 μM) for 30 minutes. Cells were exposed to the treatment regimens above for 3 hours, and the 
mRNA expression for c-Myc (b), SOX-9 (c), and VEGF (d) was analyzed by real-time polymerase chain reaction. (e) Western blot analysis showing ERK1/
2 phosphorylation using phospho-Thr202/Tyr204 ERK1/2 (P-ERK1/2) and total ERK1/2 (T-ERK1/2) antibodies. (f) Immunofluorescence analysis showing 
minimal phospho-ERK1/2 in control cells [a], cells stained with secondary antibody alone [b], optimal phosphorylation of ERK1/2 and its nuclear trans-
location in response to IL-1β at 10 and 30 minutes [c,d], and nuclear translocation and cytoplasmic redistribution of p-ERK1/2 in response to DS in the 
absence [e,f] and presence [g,h] of IL-1β. Cells were counterstained with fluorescein isothiocyanate-phalloidin to show β-actin. Experiments in (a,c-e) 
were performed in triplicate and were repeated three times in (b) and two times in (f). The error bars represent standard error of the mean (standard 
error of the mean in a-d). Gels in (e) represent one of three experiments with similar results. Φ P  < 0.05 as compared with untreated controls; *P  < 0.05 
as compared with cells treated with DS or with DS and IL-1. C, control; Cont, control; ERK1/2, extracellular receptor kinase 1/2; MTT, 3-(4,5 dimethylth-
iazolyl-2)-2,5-diphenyltetrazolium bromide; SOX-9, SRY-related protein-9; VEGF, vascular endothelial cell growth factor.
(a) (b) (c)
(d) (e) (f)
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Ser445 residues. However, B-Raf was not activated by DS
but it did suppress IL-1β-induced Ser445-B-Raf phospho-
rylation (Figure 2c).
Using a similar experimental strategy, we next exam-
ined the activation of the RAS proteins. RAS proteins are
found as GTP-bound active and GDP-bound inactive
forms. ACs exposed to the above experimental regimens
were lysed and subjected to precipitation to capture acti-
vated RAS with GST-Raf-RBD and glutathione agarose
beads. Western blot analysis revealed that DS alone or in
the presence of IL-1β induced a rapid but transient acti-
vation of RAS within 5 minutes (Figure 2d). However, IL-
1β induced a minimal RAS activation. Untreated ACs
exhibited negligible GTP-bound activated RAS. To con-
firm these observations, ACs were further pretreated
with a selective antagonist of RAS, GGT12133 (2 or 10
μM), and subsequently stimulated for 5 or 15 minutes.
GGT12133 (2 μM) completely inhibited DS-induced
ERK1/2 activation, confirming that mechanical signals
induce RAS activation in the absence or presence of an
inflammatory stimulus (Figure 2e).
Mechanical signals activate ILK to initiate ERK1/2 signaling 
cascade
ILK is shown to activate RAS proteins. To determine
whether ILK activation was necessary for mechanoacti-
vation-induced RAS activation, ACs were transfected
with plasmids containing FLAG-ILK expression vectors
containing the full-length ILK (FLAG-WT-ILK), trun-
cated N terminal (residues 1-230, FLAG-N-ILK), and the
KD ILK mutant (FLAG-KD-ILK) containing a single
mutation (Glu359 at Lys) or with pFLAG-CMV-2 vector
lacking the ILK sequence as a control [28,29]. ACs shown
in Figure 3a were untransfected (a,b) or were transfected
with FLAG-CMV-2 empty vector (c,d), FLAG-KD-ILK
Figure 2 Mitogen-activated protein kinase signaling in response to dynamic strain (DS). Articular chondrocytes (ACs) were exposed to no treat-
ment or to treatment with interleukin-1-beta (IL-1β), DS alone, or DS and IL-1β for 10 or 30 minutes and were examined by Western blot analysis for 
(a) Ser217/221-MEK1/2 phosphorylation by DS and IL-1β. Equal protein loading was confirmed by probing blots with anti-total MEK1/2 antibody. (b) 
Ser338-c-RAF phosphorylation, (c) Ser445-B-Raf phosphorylation, and (d) Ras activation following immunoprecipitation with GST-Raf-1-RBD and glu-
tathione agarose beads are shown. (e) Ras activation following pretreatment of cells with a selective Ras antagonist (2 μM GGT12133) for 30 minutes 
is shown along with the assessment of Ras-dependent phospho-Thr202/Tyr204-ERK1/2 (P-ERK1/2) 10 and 30 minutes post-activation. Anti-total ERK1/
2 IgG (T-ERK1/2) was used to normalize total input in all lanes. All experiments were performed in triplicate. Gels represent one of three experiments 
with similar results in (a-e). The graphs above gels in each figure show mean and standard error of the mean of phosphoprotein/total protein in three 
separate experiments in (A-D). *P  < 0.05 as compared with untreated control cells; **P  < 0.05 as compared with IL-1β-treated cells. DTF, dynamic ten-
sile force; ERK1/2, extracellular receptor kinase 1/2; GGT, Ras inhibitor GGT12133; GST, glutathione-S-transferase; MEK1/2, mitogen-activated protein 
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and ILK was detected by rabbit anti-ILK (a,c,e,g,i) or rab-
bit anti-FLAG antibodies (b,d,f,h,j). Cells stained with
goat anti-rabbit CY3-labeled secondary antibodies alone
did not show staining (data not shown).
Western blot analysis showed that untransfected con-
trol cells and those transfected with FLAG-WT-ILK did
not exhibit constitutive ERK1/2 phosphorylation (Figure
3b). However, within 10 minutes, exposure of untrans-
fected control cells and cells transfected with pFLAG-
CMV-2 or FLAG-WT-ILK to DS showed ERK1/2 phos-
phorylation, which remained high in cells overexpressing
WT-ILK. However, mechanoactivation of ACs trans-
fected with FLAG-N-ILK or FLAG-KD-ILK failed to
induce ERK1/2 phosphorylation in cells (Figure 3b). Den-
sitometric analysis of the same samples probed with anti-
total ERK1/2 antibody confirmed equal protein input in
all lanes (Figure 3b). ACs activated by IL-1β showed
ERK1/2 activation in cells transfected with FLAG-
mutant-ILK or FLAG-WT-ILK following 30 minutes of
activation (Figure 3c). However, cells simultaneously acti-
vated with IL-1β and DS showed ERK1/2 activation in
only the untransfected cells or those transfected with
plasmids containing FLAG-WT-ILK or pFLAG-CMV-2
(Figure 3d).
Discussion
We have shown that dynamic mechanical signals vitally
control AC proliferation and differentiation by regulating
the MAPK signaling cascade. Furthermore, the actions of
mechanical signals are sustained in the presence of proin-
flammatory signals induced by IL-1β. We have exposed
Figure 3 Mechanical signals activate integrin-linked kinase (ILK). (a) Articular chondrocytes (ACs) either were not transfected [a,b] or were trans-
fected with p-FLAG-CMV2 empty [c,d], FLAG-KD-ILK [e,f], FLAG-N-ILK [g,h], or FLAG-WT ILK [i,j]. ACs were immunostained with anti-ILK (left frames) or 
anti-FLAG (right frames) antibodies and CY3-conjugated secondary antibodies. All cells were counterstained with fluorescein isothiocyanate-phalloi-
din to visualize β-actin. Western blot analysis shows ERK1/2 activation in untransfected ACs or those transfected with FLAG-N-ILK, FLAG-KD-ILK, FLAG-
WT-ILK, or pFLAG-CMV2 exposed to (b) no strain or dynamic strain (DS) alone, (c) interleukin-1-beta (IL-1β) alone, or (d) DS and IL-1β. Frames (c,d) 
show semiquantitative estimation of bands in Western blots. All figures represent one of three similar experiments. ERK1/2, extracellular receptor ki-
nase 1/2; FLAG, polypeptide protein sequence DYKDDDDK; KD, kinase-deficient; P-ERK1/2, phospho-Thr202/Tyr204-extracellular receptor kinase 1/2; 
T-ERK1/2, total extracellular receptor kinase 1/2; WT, wild-type.
(a) (b) (c)
(d)
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controlling cell growth. During joint movement, ACs
simultaneously experience dynamic compression-, ten-
sion-, and torsion-induced forces. In vitro, ACs subjected
to 10% compression in three-dimensional microfiber or
agarose constructs exhibit many biochemical changes
similar to those of ACs exposed to 6% tensile forces. For
example, 10% compressive forces as well as 6% tensile
forces suppress proinflammatory gene induction, upregu-
late total proteoglycan contents, and aggrecan, collagen
type II, and SOX-9 mRNA induction in ACs [7,8,30-32].
Therefore, in this study, 6% tensile forces were used to
examine the signaling events induced by DS. However, so
far, the extent of compressive or tensile forces experi-
enced by ACs during joint movement in vivo is not clear.
Intracellular signal transduction by mechanical signals
begins with ILK activation. This was evident by the
observations that mechanical signals failed to induce
ERK1/2 phosphorylation in ACs transfected with
mutant-ILK or kinase activity-deficient ILK plasmids.
However, mechanical signals induced ERK1/2 activation
in ACs transfected with WT ILK or untransfected cells.
These studies revealed that ILK activation by mechanical
signals is of critical importance given the fact that integ-
rins are the putative mechanosensors of chondrocytes,
and ILK is one of the central signaling components of the
integrin complex [15]. Interestingly, mechanical signals
are also perceived via integrins to activate Rho GTPases
to regulate cytoskeletal rearrangements [33]. This indi-
cates that mechanical signals regulate diverse cellular
functions via integrin engagement.
Mechanoactivation of ACs leads to the rapid activation
of RAS. In an effort to examine whether mechanical sig-
nals regulate RAS during inflammation, we examined the
effects of IL-1β on RAS activation. IL-1β induces minimal
activation of RAS. Nevertheless, RAS activation is similar
in mechanoactivated cells irrespectively of the presence
of IL-1β. RAS activation is associated with ERK1/2-medi-
ated cell proliferation [34]. Consistent with these find-
ings, our data show that the RAS inhibitor GGT12133
attenuates ERK1/2 phosphorylation induced by mechani-
cal signals. RAS activation is central to activation of many
cell surface receptors, such as growth factor receptors,
receptor tyrosine kinases, integrins, and IL-6 receptors
[34-36], further suggesting that dynamic mechanical sig-
nals activate signaling molecules similar to other growth
factors.
To examine how mechanical signals and IL-1β regulate
ERK1/2 signaling cascade that result in differential gene
expression, we next examined the activation of Rafs [37].
Mechanical signals trigger c-Raf kinase activity by phos-
phorylating Ser338 residues. However, IL-1β induces
Ser445-B-Raf phosphorylation. B-Raf was not activated
by mechanical signals. However, mechanical signals
inhibited IL-1β-induced B-Raf activation. This disparity
in the activation of Rafs may play a critical role in the dif-
ferential processing of signals generated by IL-1β and
mechanical forces. However, the mechanisms that under-
lie this regulation of c-Raf and B-Raf remain to be eluci-
dated.
Activation of B-Raf by IL-1β or c-Raf by mechanical
signals results in MEK1/2 activation via Ser217/221 phos-
phorylation [19]. Subsequently, MEK1/2 activates ERK1/
2 by phosphorylating both Thr202/Tyr204 residues. Fol-
lowing mechanoactivation, phosphorylated ERK1/2 rap-
idly translocates to the nucleus and is redistributed to the
cell surface. ERK proteins after activation translocate to
the nuclear compartment, where they act as the main
executor of ERK1/2 biological functions, and channel a
diverse array of signals via downstream targets. Addition-
ally, ERK dimers and scaffolds translocate to cognate
cytoplasmic substrates, where they stabilize ERK1/2 and
Myc functions in cell proliferation [35,38,39].
Interestingly, ERK1/2 activation is temporally regulated
in response to DS as well as IL-1β. DS rapidly induces
ERK1/2 phosphorylation, which is observed within 10
minutes. IL-1β-induced ERK1/2 phosphorylation is
apparent at 30 minutes. It is likely that DS, by activating
kinases upstream of ERK1/2, initiates a feedback loop
that suppresses IL-1β-induced ERK1/2 activation. Such
early activation of ERK1/2 by DS may likely play a role in
sustaining its effects in the presence of IL-1β.
Mechanoactivation of ACs leads to c-Myc, VEGF, and
SOX-9 mRNA expressions, all of which have been impli-
cated in the proliferative response of cells to a variety of
stimuli [35,40]. Furthermore, ERK1/2 activation is
required for c-Myc, SOX-9, and VEGF mRNA expression,
as evidenced by the suppression of their transcriptional
activation by PD98059. We have also observed that
ERK1/2 activation by IL-1β fails to induce SOX-9 or
VEGF expression. This may explain the suppression of
AC proliferation in the presence IL-1β. These findings
again point to similarities between mechanical signals
and other growth factors that use the ERK1/2/Myc sig-
naling cascade to regulate cell proliferation [23,36,41].
Furthermore, the fact that mechanical signals upregulate
c-Myc, SOX-9, and VEGF in the presence of IL-1β sup-
ports the benefits of mechanoactivation of ACs in the
inflamed cartilage.
Conclusions
Our findings demonstrate for the first time that mechani-
cal signals suppress the ERK1/2 signaling cascade of IL-
1β, indicating a critical role for these signals in rescuing
cartilage from the detrimental effects of IL-1β during
inflammation. The cellular decision-making in response
to mechanical forces occurs swiftly and is phospho-
relayed via ILK to downstream signaling targets. None-
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Page 8 of 9theless, activation of intermediate signaling molecules
like c-Raf and B-Raf may be critical in regulating ERK1/2
transcriptional activity in response to mechanosignaling.
Only c-Raf is activated by mechanical signals but it inhib-
its B-Raf activation by IL-1β. Activated hetrodimers and
homodimers of B-Raf and c-Raf regulate downstream
activation of MAPKs. By suppressing B-Raf activation,
mechanical signals may likely alter a critical event impor-
tant for the downstream IL-1β signaling. This may lead to
the SOX-9, VEGF, and Myc upregulation responsible for
cell proliferation in IL-1β-treated cells. Earlier studies
have shown that mechanical signals also suppress inflam-
mation by inhibiting nuclear factor-kappa-B activation
and thus expression of proinflammatory genes, such as
IL-1β, TNF-α, inducible nitric oxide synthase, matrix
metalloproteinases, and lipopolysaccharide [3,7,8,25].
The present findings thus demonstrate, at least in part,
the basis for the regenerative potential of mechanical sig-
nals in arthritic diseases. Furthermore, studies show the
importance of the ERK1/2 signaling cascade in mediating
proliferative actions of mechanical signals in proinflam-
matory environments.
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